Global leaders in hypertension and cardiovascular research share with us the details of research articles currently of interest to them or their motivational contributions not necessarily of a scientific nature.
Dr. Daniel Piskorz was the 2011 – 2013 President of the Argentina Hypertension Society and the 2017 President of the Argentina Cardiology Federation, and has been a member of the Board of Directors of the Latin-American Hypertension Society since 2013. He is currently the Chief of the Cardiovascular Research Center at Rosario British Sanatorium and Board of Directors of the Cardiology Institute at Rosario British Sanatorium.
Urine Haptoglobin and Haptoglobin-Related Protein Predict Response to Spironolactone in Patients with Resistant Hypertension.
Resistant hypertension double the risk of end stage renal disease, increase by almost 60 % the risk of stroke and 45 % of coronary artery disease, and enhance by approximately 30 % the mortality (Muntner P. Hypertension 2014; 64: 1012 - 1021.).
Read More 05/04/2019